SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-041160
Filing Date
2018-06-20
Accepted
2018-06-20 09:13:56
Documents
5
Period of Report
2018-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-14696_68k.htm 8-K 32627
2 EX-1.1 a18-14696_6ex1d1.htm EX-1.1 227244
3 EX-4.1 a18-14696_6ex4d1.htm EX-4.1 136892
4 EX-99.1 a18-14696_6ex99d1.htm EX-99.1 11085
5 GRAPHIC g146966mmi001.jpg GRAPHIC 2883
  Complete submission text file 0001104659-18-041160.txt   413165
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 18908762
SIC: 2834 Pharmaceutical Preparations